Firebrick Pharma (ASX:FRE) Price-to-Tangible-Book : 6.33 (As of Jun. 24, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Price-to-Tangible-Book?

As of today (2024-06-24), Firebrick Pharma's share price is A$0.057. Firebrick Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.01. Hence, Firebrick Pharma's Price to Tangible Book Ratio of today is 6.33.

The historical rank and industry rank for Firebrick Pharma's Price-to-Tangible-Book or its related term are showing as below:

ASX:FRE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.41 Med: 6.62 Max: 11.07
Current: 5.7

During the past 3 years, Firebrick Pharma's highest Price to Tangible Book Ratio was 11.07. The lowest was 5.41. And the median was 6.62.

ASX:FRE's Price-to-Tangible-Book is ranked worse than
82.11% of 861 companies
in the Drug Manufacturers industry
Industry Median: 2.31 vs ASX:FRE: 5.70

A closely related ratio is called PB Ratio. As of today, Firebrick Pharma's share price is A$0.057. Firebrick Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.01. Hence, Firebrick Pharma's P/B Ratio of today is 6.33.

Firebrick Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Firebrick Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Price-to-Tangible-Book Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Price-to-Tangible-Book

5.41

11.07

Firebrick Pharma Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	5.41	7.67	11.07	5.56

Competitive Comparison of Firebrick Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Firebrick Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Firebrick Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's Price-to-Tangible-Book falls into.

Firebrick Pharma Price-to-Tangible-Book Calculation

Firebrick Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.057	/	0.009
	=	6.33

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Firebrick Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma (ASX:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma (ASX:FRE) Headlines

No Headlines